| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2090589 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 1930 uM pretreated before ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 2. | ALA2090590 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.3 uM pretreated before ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 3. | ALA2090591 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 3.3 uM pretreated before ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 4. | ALA2090592 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 33 uM pretreated before ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 5. | ALA2090593 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 330 uM pretreated before ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 6. | ALA2090706 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.054 uM pretreated before colcemid by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 7. | ALA2090707 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.3 uM pretreated before colcemid by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 8. | ALA2090708 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 3.3 uM pretreated before colcemid by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 9. | ALA2090709 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 33 uM pretreated before colcemid by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 10. | ALA2090710 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 330 uM pretreated before colcemid by cytokinesis blocking technique (Rvb = 3.33 +/- 0.88 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 11. | ALA2090711 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 1930 uM co-treated with ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 12. | ALA2090712 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.3 uM co-treated with ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 13. | ALA2090713 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 3.3 uM co-treated with ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 14. | ALA2090714 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 33 uM co-treated with ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 15. | ALA2090715 | Functional | Antimutagenic activity in human PBL assessed as inhibition of ethyl methanesulfonate-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 330 uM co-treated with ethyl methanesulfonate by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 16. | ALA2090716 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.054 uM co-treated with colcemid by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 17. | ALA2090717 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 0.3 uM co-treated with colcemid by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 18. | ALA2090718 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 3.3 uM co-treated with colcemid by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 19. | ALA2090719 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 33 uM co-treated with colcemid by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature | |
| 20. | ALA2090720 | Functional | Antimutagenic activity in human PBL assessed as inhibition of colcemid-induced frequency of micronucleus per 1000 binucleated lymphocyte cells at 330 uM co-treated with colcemid by cytokinesis blocking technique (Rvb = 4.00 +/- 0.41 micronucleus frequency/1000 binucleated lymphocyte cells) | Homo sapiens | 1 | ALA2086272 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!